Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies
Frontiers in Pharmacology · 02.02.2026 · 17
DOI: 10.3389/fphar.2026.1681783 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.02.2026. Verfasst von Julia Khinchin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY, United States. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Metformin, a cornerstone therapy for type 2 diabetes mellitus, has emerged as a promising cardioprotective agent with effects that extend well beyond glycemic control. This review synthesizes current evidence on the molecular and cellular mechanisms underlying metformin’s glycemic control and cardiovascular benefits, highlighting both AMPK-dependent and AMPK-independent pathways. We examine its modulation of mitochondrial function, oxidative stress, inflammation, autophagy, and apoptosis across major cardiac conditions, including ischemia/reperfusion injury, heart failure, diabetic cardiomyopathy, and anthracycline-induced cardiotoxicity. By integrating evidence from both preclinical and clinical studies, we evaluate the translational potential of metformin’s pleiotropic actions across specific cardiac pathologies and outline key directions for future research and therapeutic innovation. Together, these insights highlight metformin’s promise in reshaping cardiovascular care beyond its traditional role in diabetes management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY, United States.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Khinchin, J., Rakoubian, A., Romano, V., Ryan, T., Yarbro, J., Kobayashi, S., & Liang, Q. (2026). Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1681783
Vancouver
Khinchin J, Rakoubian A, Romano V, Ryan T, Yarbro J, Kobayashi S, et al. Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1681783
BibTeX
@article{Khinchin2026,
author = {Khinchin, Julia and Rakoubian, Ani and Romano, Valentina and Ryan, Thomas and Yarbro, Johnathan and Kobayashi, Satoru and Liang, Qiangrong},
title = {Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1681783}
}
EUVIMED